Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.
Panaccione
Remo
R
University of Calgary, Calgary, Canada.
Fedorak
Richard N
RN
Aumais
Guy
G
Bernstein
Charles N
CN
Bitton
Alain
A
Croitoru
Ken
K
Enns
Robert
R
Feagan
Brian
B
Fishman
Marty
M
Greenberg
Gordon
G
Griffiths
Anne
A
Marshall
John K
JK
Rasul
Imran
I
Sadowski
Daniel
D
Seidman
Ernest
E
Steinhart
Hillary
H
Sutherland
Lloyd
L
Walli
Eric
E
Wild
Gary
G
Williams
C Noel
CN
Zachos
Mary
M
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D000075202:Contraindications; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab